All New HIC Column for High Throughput Analyses: BioPro HIC HT
Mar 24 2020 Read 1312 Times
YMC’s latest hydrophobic interaction chromatography column, BioPro HIC HT, is especially designed for biopharmaceuticals such as antibody-drug-conjugates (ADCs). Higher flow rates can be applied due to an extremely high-pressure stability, which allows very short run times and high sample throughput.
BioPro HIC HT columns are the ideal choice for drug-to-antibody ratio (DAR) determination due to a novel and optimised surface chemistry. Higher resolution is offered compared to conventional HIC columns as its surface modification suppresses excessive or strong absorption of ACDs and result in highly reliable quantifications.
The rigid 2.3 µm non-porous polymer particles with butyl modification are pressure tolerant up to 400 bar and allow rapid analyses by increased flow rates without loss of resolution. Such fast runs are not possible with other HIC columns due to their much lower pressure limit, which is usually only the half that of BioPro HIC HT.
BioPro HIC HT is the perfect solution for quality control applications not only due to the possibility of high throughput runs, but also the excellent batch-to-batch reproducibility provided by YMC.
The reproducibility together with the high column stability ensures highest reliability for your separations!
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Articles - Elimination of the Sample Solvent Effect when Analysing Water Solutions of Basic Peptides by HILIC - Method Development and Validation of Simultaneous Determinatio...
View all digital editions
May 31 2020 Houston, TX, USA
May 31 2020 Baltimore, MD, USA
Jun 07 2020 Taipei, Taiwan
Jun 20 2020 San Diego, CA, USA
Aug 29 2020 Rio de Janeiro, Brazil